For patients with NSCLC squamous cell subtype without a targetable mutation, the median OS with chemotherapy and IO by PDL‐1 status is as follows: 14.0 (PDL‐1 1%–49%) and 15.9 (PDL‐1 < 1%) (42). The gene discussed is CD274; the disease is non-small cell lung carcinoma.